What can be added to Lexapro (escitalopram) 20 mg to help a 54-year-old female patient with increased anxiety, irritability, and low libido?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Increased Anxiety, Irritability, and Low Libido in a Patient on Escitalopram

Bupropion is the most appropriate medication to add to escitalopram for this 54-year-old female patient experiencing increased anxiety, irritability, and low libido. 1

Understanding the Current Situation

  • The patient is currently on escitalopram 20 mg, which is the maximum recommended dose for anxiety disorders 2
  • She is experiencing three main issues: increased anxiety, irritability, and low libido
  • Sexual dysfunction is a common side effect of SSRIs like escitalopram, affecting up to 59.1% of patients on antidepressants 3
  • Escitalopram specifically causes decreased libido in 3% of female patients and anorgasmia in 3% of female patients according to FDA data 2

First-Line Augmentation Option

  • Bupropion (starting at 37.5 mg every morning, gradually increasing to 150 mg twice daily) is the optimal choice for augmentation based on:
    • Demonstrated efficacy in resolving SSRI-induced sexual dysfunction (94% of patients had complete or partial resolution of orgasm dysfunction) 1
    • Activating properties that can help with energy levels and potentially address anxiety when combined with an SSRI 4
    • Low risk of drug interactions with escitalopram, which has minimal effects on CYP450 isoenzymes 4

Dosing and Administration

  • Start bupropion at 37.5 mg every morning, then increase by 37.5 mg every 3 days 4
  • Target dose is 150 mg twice daily, with the second dose given before 3 pm to minimize insomnia 4
  • Monitor for increased anxiety initially, as bupropion can be activating 4
  • Assess response after 4-6 weeks of combined therapy 5

Alternative Options if Bupropion is Ineffective or Contraindicated

  1. Mirtazapine (starting at 7.5 mg at bedtime, up to 30 mg):

    • Associated with much lower rates of sexual dysfunction (24.4%) compared to SSRIs (58-73%) 3
    • Can be particularly helpful if the patient also has insomnia, as it promotes sleep 4
    • Well-tolerated and can help with anxiety symptoms 4
  2. Consider switching from escitalopram to another agent:

    • If augmentation fails, switching to mirtazapine monotherapy may be beneficial as it has a sexual dysfunction rate of only 24.4% 3, 6
    • Alternatively, consider nefazodone which has very low rates of sexual dysfunction (8%) 3

Monitoring and Follow-up

  • Assess response to combined therapy after 2-4 weeks 5
  • Use standardized assessment tools to monitor anxiety symptoms and sexual function 5
  • Monitor for potential drug interactions, though escitalopram has a favorable drug interaction profile compared to other SSRIs 4
  • Be aware that bupropion is contraindicated in patients with seizure disorders 4

Important Caveats and Considerations

  • Bupropion should not be used in patients with seizure disorders or eating disorders due to increased seizure risk 4
  • The second dose of bupropion should be given before 3 pm to minimize insomnia 4
  • Sexual dysfunction from SSRIs can sometimes persist even after discontinuation of the medication, so early intervention is important 7
  • If anxiety worsens with bupropion, consider lowering the dose or switching to mirtazapine 4, 6
  • Avoid combining escitalopram with other serotonergic medications due to risk of serotonin syndrome 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tratamiento del Trastorno de Ansiedad Generalizada Resistente a Monoterapia con Escitalopram

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sexual Dysfunction in Patients with Antidepressant-treated Anxiety or Depressive Disorders: a Pragmatic Multivariable Longitudinal Study.

East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.